| 1 |
Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in China[J]. N Engl J Med, 2016, 375(9): 905-906.
|
| 2 |
Ene-Iordache B, Perico N, Bikbov B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study[J]. Lancet Glob Health, 2016, 4(5): e307-e319.
|
| 3 |
Tonelli M, Karumanchi SA, Thadhani R. Epidemiology and mechanisms of uremia-related cardiovascular disease[J]. Circulation, 2016, 133(5): 518-536.
|
| 4 |
Saleh MA, El Kilany WM, Keddis VW, et al. Effect of high flow arteriovenous fistula on cardiac function in hemodialysis patients[J]. Egypt Heart J, 2018, 70(4): 337-341.
|
| 5 |
Lin YP, Chen CH, Yu WC, et al. Left ventricular mass and hemodynamic overload in normotensive hemodialysis patients[J]. Kidney Int, 2002, 62(5): 1828-1838.
|
| 6 |
Scholz SS, Vukadinović D, Lauder L, et al. Effects of arteriovenous fistula on blood pressure in patients with end-stage renal disease: a systematic meta-analysis[J]. J Am Heart Assoc, 2019, 8(4): e011183.
|
| 7 |
Ori Y, Korzets A, Katz M, et al. The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy[J]. Am J Kidney Dis, 2002, 40(4): 745-752.
|
| 8 |
Alkhouli M, Sandhu P, Boobes K, et al. Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease[J]. Nefrologia, 2015, 35(3): 234-245.
|
| 9 |
Clemmer JS, Pruett WA, Hester RL, et al. Preeminent role of the cardiorenal axis in the antihypertensive response to an arteriovenous fistula: an in silico analysis[J]. Am J Physiol Heart Circ Physiol, 2019, 317(5): H1002-H1012.
|
| 10 |
Zoccali C, Benedetto FA, Mallamaci F, et al. Left ventricular mass monitoring in the follow-up of dialysis patients:prognostic value of left ventricular hypertrophy progression[J]. Kidney Int, 2004, 65(4): 1492-1498.
|
| 11 |
袁伟杰, 湛冯岚, 付鹏, 等. 动静脉内瘘对维持性血液透析患者左心室结构及功能的影响[J]. 中华肾脏病杂志, 2002, 18(4): 262-265.
|
| 12 |
Ayer A, Mills C, Donovan C, et al. Associations of microvascular dysfunction with cardiovascular outcomes: The cardiac, endothelial function and arterial stiffness in ESRD (CERES) cohort[J]. Hemodial Int, 2019, 23(1): 58-68.
|
| 13 |
Shah AM, Cikes M, Prasad N, et al. Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction[J]. J Am Coll Cardiol, 2019, 74(23): 2858-2873.
|
| 14 |
陈迈, 杨波, 林谨, 等. 组织多普勒Tei指数评价动静脉内瘘术后不同流量负荷患者左室功能的研究[J]. 临床超声医学杂志, 2019, 21(6): 422-425.
|
| 15 |
Kramann R, Erpenbeck J, Schneider RK, et al. Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD[J]. J Am Soc Nephrol, 2014, 25(10): 2351-2365.
|
| 16 |
Li J, Li A, Wang J, et al. Early left ventricular dysfunction detected by speckle tracking in long-term hemodialysis patients with valvular calcification[J]. Cardiorenal Med, 2019, 9(1): 22-30.
|
| 17 |
Marwick TH. Ejection fraction pros and cons: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2018, 72(19): 2360-2379.
|
| 18 |
Pedrizzetti G, Lapinskas T, Tonti G, et al. The relationship between EF and Strain permits a more accurate assessment of LV systolic function[J]. JACC Cardiovasc Imaging, 2019,12(9):1893-1895.
|
| 19 |
杨菲, 陈勇, 于海迪, 等. 二维斑点追踪技术评价食管癌患者放疗后左心室舒张功能[J]. 中华放射肿瘤学杂志, 2019, 28(5): 344-348.
|
| 20 |
Sandhu JS, Wander GS, Gupta ML, et al. Hemodynamic effects of arteriovenous fistula in end-stage renal failure[J]. Ren Fail, 2004, 26(6): 695-701.
|
| 21 |
Ragupathi L, Johnson D, Marhefka GD. Right ventricular enlargement within months of arteriovenous fistula creation in 2 hemodialysis patients[J]. Tex Heart Inst J, 2016, 43(4): 350-353.
|
| 22 |
Hickson LJ, Negrotto SM, Onuigbo M, et al. Echocardiography criteria for structural heart disease in patients with end-stage renal disease initiating hemodialysis[J]. J Am Coll Cardiol, 2016, 67(10): 1173-1182.
|
| 23 |
Reddy Y, Obokata M, Dean PG, et al. Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease[J]. Eur Heart J, 2017, 38(24): 1913-1923.
|
| 24 |
Said K, Hassan M, Farouk M, et al. Right ventricular function after creation of an atriovenous fistula in patients with end stage renal disease[J]. Heart Lung Circ, 2019, 28(6): 884-892.
|
| 25 |
Xu B, Harb S, Hawwa N, et al. Impact of end-stage renal disease on left and right ventricular mechanics: does kidney transplantation reverse the abnormalities?[J]. JACC Cardiovasc Imaging, 2017, 10(9): 1081-1083.
|
| 26 |
Jurcut R, Giusca S, La Gerche A, et al. The echocardiographic assessment of the right ventricle: what to do in 2010?[J]. Eur J Echocardiogr, 2010, 11(2): 81-96.
|
| 27 |
Ishizu T, Seo Y, Atsumi A, et al. Global and regional right ventricular function assessed by novel three-dimensional speckle-tracking echocardiography[J]. J Am Soc Echocardiogr, 2017, 30(12): 1203-1213.
|
| 28 |
Satriano A, Pournazari P, Hirani N, et al. Characterization of right ventricular deformation in pulmonary arterial hypertension using three-dimensional principal strain analysis[J]. J Am Soc Echocardiogr, 2019, 32(3): 385-393.
|
| 29 |
杨性安, 潘卫星, 朱佳. 二维斑点追踪成像技术评价糖尿病患者前期右心室纵向应变及应变率[J/CD]. 中华医学超声杂志(电子版), 2018, 15(1): 48-52.
|
| 30 |
Yigla M, Fruchter O, Aharonson D, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients[J]. Kidney Int, 2009, 75(9): 969-975.
|
| 31 |
Bolignano D, Rastelli S, Agarwal R, et al. Pulmonary hypertension in CKD[J]. Am J Kidney Dis, 2013, 61(4): 612-622.
|
| 32 |
Sarnak MJ, Roberts KE. Pulmonary hypertension in CKD: some answers, yet more questions[J]. J Am Soc Nephrol, 2016, 27(3): 661-663.
|
| 33 |
Babadjanov J, Miler R, Niebauer K, et al. Arteriovenous fistula creation for end-stage renal disease may worsen pulmonary hypertension[J]. Ann Vasc Surg, 2016, 36: 293.e1-293.e3.
|
| 34 |
Havlucu Y, Kursat S, Ekmekci C, et al. Pulmonary hypertension in patients with chronic renal failure[J]. Respiration, 2007, 74(5): 503-510.
|
| 35 |
Beigi AA, Sadeghi AM, Khosravi AR, et al. Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure[J]. J Vasc Access, 2009, 10(3): 160-166.
|
| 36 |
张学铭, 杨梦慧, 庄琦, 等. 二维斑点追踪技术对肺动脉高压患者右心房功能及预后的评估价值[J]. 山东医药, 2019, 59(13): 1-5.
|
| 37 |
Li Y, Wang T, Haines P, et al. Prognostic value of right ventricular two-dimensional and three-dimensional speckle-tracking strain in pulmonary arterial hypertension: superiority of longitudinal strain over circumferential and radial strain[J]. J Am Soc Echocardiogr, 2020, 33(8): 985-994.e1.
|
| 38 |
Lee T, Qian J, Thamer M, et al. Tradeoffs in vascular access selection in elderly patients initiating hemodialysis with a catheter[J]. Am J Kidney Dis, 2018, 72(4): 509-518.
|
| 39 |
Hod T, Patibandla BK, Vin Y, et al. Arteriovenous fistula placement in the elderly: when is the optimal time?[J]. J Am Soc Nephrol, 2015, 26(2): 448-456.
|
| 40 |
中国医院协会血液净化中心分会血管通路工作组. 中国血液透析用血管通路专家共识(第2版)[J]. 中国血液净化, 2019, 18(6): 365-381.
|
| 41 |
Kurita N, Mise N, Tanaka S, et al. Arteriovenous access closure in hemodialysis patients with refractory heart failure: a single center experience[J]. Ther Apher Dial, 2011, 15(2): 195-202.
|
| 42 |
Chaumais MC, Djessas M, Thuillet R, et al. Additive protective effects of sacubitril/valsartan and bosentan on vascular remodeling in experimental pulmonary hypertension[J]. Cardiovasc Res, 2020, cvaa200.
|
| 43 |
Sulemane S, Panoulas VF, Nihoyannopoulos P. Echocardiographic assessment in patients with chronic kidney disease: Current update[J]. Echocardiography, 2017, 34(4): 594-602.
|
| 44 |
Potter E, Marwick TH. Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction[J]. JACC Cardiovasc Imaging, 2018, 11(2 Pt 1): 260-274.
|
| 45 |
钱胜利, 杨莉, 杜锐, 等. 实时三维斑点追踪技术评价潜水员水肺潜水后左心室收缩功能改变[J/CD]. 中华医学超声杂志(电子版), 2019, 16(12): 937-942.
|
| 46 |
张清凤, 王胰, 张红梅, 等. 二维斑点追踪参数在平板运动负荷超声中的应用研究[J/OL]. 中华医学超声杂志(电子版), 2020, 17(8): 753-758.
|
| 47 |
梁梦婕, 金怡, 郑哲岚. 超声二维斑点追踪技术在蒽环类化疗药物心脏毒性监测中的应用价值[J/CD]. 中华医学超声杂志(电子版), 2019, 16(10): 749-755.
|